ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Impact of social determinants on the development, diagnosis, and treatment of cancer: recommended public health interventions.
Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Informational and structural barriers to exercise oncology care in Spain: development of the MOVE-Onco questionnaire and preliminary findings.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Social inequities in oncology are driven by intersecting determinants of health and healthcare at multiple levels. Inequalities in the social determinants of health (SDOH) result in delayed cancer diagnoses, sub-optimal treatment, and increased mortality rates in patients with lower socioeconomic status (SES). This article describes the SDOH that influence the field of oncology, with the aim of identifying inadequacies in clinical practice and research, and raising awareness among key stakeholders. Some SDOH cannot be modified (age, race, sex and gender), while others are considered modifiable (lifestyle, diet, exercise, unwanted loneliness, economic resources). We have developed practical recommendations for national policymakers, hospital management, healthcare professionals (HCPs), and patients that address the root causes of social disparities in cancer care. HCPs within multidisciplinary teams who manage patients with cancer are in a key position to consider and address the SDOH that impact patients, particularly those of lower SES, in the clinical oncological setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.